- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MYGN
Recent news which mentions MYGN
Earnings Scheduled For August 3, 2023
August 03, 2023
From Benzinga
Cramer Calls Tech Giant A 'Great' Long-Term Play, But In The Short Term It's Just 'Too Hot'
June 22, 2023
From Benzinga
3 Gene Testing Stocks to Buy Before They Take Off
June 17, 2023
From InvestorPlace
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 23, 2023
From Benzinga
From Benzinga
Lilium, Myriad Genetics And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
May 23, 2023
From Benzinga
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 05, 2023
From Benzinga
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
March 25, 2023
From InvestorPlace
Here’s one for the battered bulls: the second-largest sector in the S&P 500 is stirring to life, says this strategist.
March 22, 2023
From MarketWatch
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 01, 2023
From Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
March 01, 2023
From Benzinga
3 Gene Editing Stocks With the Best Long-Term Potential
January 25, 2023
From InvestorPlace
Insiders Selling DocuSign, Adobe And 2 Other Stocks
January 24, 2023
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
January 18, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
December 30, 2022
From Benzinga
From Benzinga
Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast
November 01, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 01, 2022
From Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
November 01, 2022
From Benzinga
Dow Drops Over 200 Points; Crude Oil Rises Sharply
November 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 01, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.